Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Yaccoby · SciRah

Researcher profile · Semantic Scholar

S. Yaccoby

Share profile

S. Yaccoby — researcher profile on SciRah

h-index: 45
Works: 167
Citations: 6,914

Most-cited papers

Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.
L. Rasche, E. Angtuaco, J. McDonald, Amy F. Buros +18 more
2017Blood241 citations Open access
Semantic Scholar
Combinatorial efficacy of anti-CS1 monoclonal antibody elotuzumab (HuLuc63) and bortezomib against multiple myeloma
F. van Rhee, S. Szmania, Myles B. C. Dillon, A. V. van Abbema +15 more
2009Molecular Cancer Therapeutics173 citations Open access
Semantic Scholar
Ex Vivo Expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo In High-Risk Relapsed Multiple Myeloma Patients
S. Szmania, N. Lapteva, T. Garg, Amy D. Greenway +18 more
2015Journal of immunotherapy163 citations Open access
Semantic Scholar
The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo
A. Pennisi, Xin Li, W. Ling, Sharmin Khan +2 more
2009American journal of hematology/oncology151 citations Open access
Semantic Scholar
The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma.
L. Rasche, E. Angtuaco, Terri L Alpe, G. Gershner +18 more
2018Blood107 citations Open access
Semantic Scholar
Highly activated and expanded natural killer cells for multiple myeloma immunotherapy
T. Garg, S. Szmania, Junaid A. Khan, A. Hoering +16 more
2012Haematologica106 citations Open access
Semantic Scholar
Advances in the understanding of myeloma bone disease and tumour growth
S. Yaccoby
2010British Journal of Haematology98 citations Open access
Semantic Scholar
Identification of early growth response protein 1 (EGR-1) as a novel target for JUN-induced apoptosis in multiple myeloma.
Lijuan Chen, Siqing Wang, Yi-Ming Zhou, Xiao-Song Wu +7 more
2010Blood93 citations Open access
Semantic Scholar
Human Placenta-Derived Adherent Cells Prevent Bone loss, Stimulate Bone formation, and Suppress Growth of Multiple Myeloma in Bone
Xin Li, W. Ling, A. Pennisi, Yuping Wang +15 more
2011Stem Cells85 citations Open access
Semantic Scholar
The level of deletion 17p and bi-allelic inactivation of TP53 has a significant impact on clinical outcome in multiple myeloma
S. Thanendrarajan, E. Tian, Ping-Ping Qu, P. Mathur +17 more
2017Haematologica76 citations Open access
Semantic Scholar
Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data
S. Waheed, A. Mitchell, S. Usmani, J. Epstein +11 more
2013Haematologica76 citations Open access
Semantic Scholar
A cyclin-dependent kinase inhibitor, dinaciclib, impairs homologous recombination and sensitizes multiple myeloma cells to PARP inhibition
D. A. Alagpulinsa, S. Ayyadevara, S. Yaccoby, R. S. Shmookler Reis
2015Molecular Cancer Therapeutics69 citations Open access
Semantic Scholar
Role of Bruton’s tyrosine kinase in myeloma cell migration and induction of bone disease
Rakesh Bam, W. Ling, Sharmin Khan, A. Pennisi +8 more
2013American journal of hematology/oncology65 citations Open access
Semantic Scholar
Microhomology-mediated end joining drives complex rearrangements and overexpression of MYC and PVT1 in multiple myeloma
A. Mikulasova, C. Ashby, R. Tytarenko, Ping-Ping Qu +18 more
2019Haematologica58 citations Open access
Semantic Scholar
Osteoblastogenesis and tumor growth in myeloma
S. Yaccoby
2010Leukemia and Lymphoma58 citations Open access
Semantic Scholar
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients
M. Zangari, S. Yaccoby, L. Pappas, F. Cavallo +8 more
2011Haematologica55 citations Open access
Semantic Scholar
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120)
R. Khan, M. Dhodapkar, A. Rosenthal, C. Heuck +13 more
2015Haematologica54 citations Open access
Semantic Scholar
NAMPT/PBEF1 enzymatic activity is indispensable for myeloma cell growth and osteoclast activity
S. U. Venkateshaiah, Sharmin Khan, W. Ling, Rakesh Bam +6 more
2013Experimental Hematology52 citations Open access
Semantic Scholar
Risk factors for MDS and acute leukemia following total therapy 2 and 3 for multiple myeloma.
S. Usmani, J. Sawyer, A. Rosenthal, M. Cottler-Fox +16 more
2013Blood48 citations Open access
Semantic Scholar
Consequences of Daily Administered Parathyroid Hormone on Myeloma Growth, Bone Disease, and Molecular Profiling of Whole Myelomatous Bone
A. Pennisi, W. Ling, Xin Li, Sharmin Khan +4 more
2010PLoS ONE48 citations Open access
Semantic Scholar
Characterization of the Molecular Mechanism of the Bone-Anabolic Activity of Carfilzomib in Multiple Myeloma
Bo Hu, Yu Chen, S. Usmani, Shi-Qiao Ye +9 more
2013PLoS ONE43 citations Open access
Semantic Scholar
Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth
Xin Li, W. Ling, Sharmin Khan, S. Yaccoby
2012Journal of Bone and Mineral Research39 citations Open access
Semantic Scholar
The Pattern of Mesenchymal Stem Cell Expression Is an Independent Marker of Outcome in Multiple Myeloma
C. Schinke, Ping-Ping Qu, S. Mehdi, A. Hoering +9 more
2018Clinical Cancer Research36 citations Open access
Semantic Scholar
Dose-dense and less dose-intense Total Therapy 5 for gene expression profiling-defined high-risk multiple myeloma
Y. Jethava, A. Mitchell, M. Zangari, S. Waheed +20 more
2016Blood Cancer Journal33 citations Open access
Semantic Scholar
The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype
C. Schinke, A. Hoering, Hongwei Wang, V. Carlton +27 more
2017Haematologica30 citations Open access
Semantic Scholar
CYR61/CCN1 overexpression in the myeloma microenvironment is associated with superior survival and reduced bone disease.
Sarah K. Johnson, J. Stewart, Rakesh Bam, Ping-Ping Qu +5 more
2014Blood26 citations Open access
Semantic Scholar
Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes
S. Mehdi, Sarah K. Johnson, J. Epstein, M. Zangari +9 more
2018British Journal of Haematology22 citations Open access
Semantic Scholar
Primary myeloma interaction and growth in coculture with healthy donor hematopoietic bone marrow
Rakesh Bam, Sharmin Khan, W. Ling, S. S. Randal +4 more
2015BMC Cancer19 citations Open access
Semantic Scholar
Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers
A. Mikulasova, D. Kent, Marco Trevisan-Herraz, N. Karataraki +17 more
2020bioRxiv18 citations Open access
Semantic Scholar
Two States of Myeloma Stem Cells.
S. Yaccoby
2018Clinical Lymphoma, Myeloma & Leukemia16 citations
Semantic Scholar
A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment
D. A. Alagpulinsa, S. Yaccoby, S. Ayyadevara, R. S. Shmookler Reis
2015Cancer Biology & Therapy16 citations Open access
Semantic Scholar
Adverse metaphase cytogenetics can be overcome by adding bortezomib and thalidomide to fractionated melphalan transplants
Y. Jethava, A. Mitchell, J. Epstein, M. Zangari +17 more
2016Clinical Cancer Research13 citations Open access
Semantic Scholar
Extensive remineralization of large pelvic lytic lesions following total therapy treatment in patients with multiple myeloma
M. Mohan, Rohan S. Samant, D. Yoon, Amy F. Buros +12 more
2017Journal of Bone and Mineral Research12 citations Open access
Semantic Scholar
Repression of Multiple Myeloma Growth and Preservation of Bone with Combined Radiotherapy and Anti-angiogenic Agent
D. Jia, Nathan A. Koonce, R. Halakatti, Xin Li +9 more
2010Radiation Research12 citations Open access
Semantic Scholar
The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma
X. Papanikolaou, Daisy V. Alapat, A. Rosenthal, Caleb K Stein +16 more
2015Leukemia11 citations Open access
Semantic Scholar
The Clinical Impact of Macrofocal Disease in Multiple Myeloma Differs Between Presentation and Relapse
L. Rasche, Amy F. Buros, N. Weinhold, Caleb K Stein +13 more
201610 citations
Semantic Scholar
GPRC5D Is a Cell Surface Plasma Cell Marker Whose Expression Is High In Myeloma Cells and Reduced Following Coculture With Osteoclasts
S. U. Venkateshaiah, Rakesh Bam, Xin Li, Sharmin Khan +3 more
20139 citations
Semantic Scholar
PHF19 inhibition as a therapeutic target in Multiple Myeloma
C. Schinke, Jordan T. Bird, Ping-Ping Qu, S. Yaccoby +16 more
2021Current Research in Translational Medicine8 citations Open access
Semantic Scholar
High Risk Multiple Myeloma Demonstrates Marked Spatial Genomic Heterogeneity Between Focal Lesions and Random Bone Marrow; Implications for Targeted Therapy and Treatment Resistance
N. Weinhold, S. Chavan, C. Heuck, O. Stephens +17 more
20158 citations
Semantic Scholar
EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression
W. Ling, Sarah K. Johnson, Syed J Mehdi, Daisy V. Alapat +6 more
2023Cancers5 citations Open access
Semantic Scholar
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
S. Thanendrarajan, F. Davies, G. Morgan, C. Schinke +8 more
2016Immunotherapy5 citations
Semantic Scholar
Growth and dormancy control of myeloma cells by mesenchymal stem cells.
S. Mehdi, K. Ghatak, W. Ling, Sarah K. Johnson +7 more
2023Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis4 citations Open access
Semantic Scholar
Mesenchymal Stem Cells Preconditioned with Myeloma Cells from High-Risk Patients Support the Growth of Myeloma Cells from Low-Risk Patients
S. Mehdi, Sharmin Khan, W. Ling, R. Shelton +8 more
20164 citations
Semantic Scholar
The role of the proteasome in bone formation and osteoclastogenesis
S. Yaccoby
20104 citations
Semantic Scholar
Bruton's Tyrosine Kinase (BTK) Is Indispensable for Myeloma Cell Migration towards SDF-1 and Induction of Osteoclastogenesis and Osteolytic Bone Disease
Rakesh Bam, A. Pennisi, Xin Li, Sharmin Khan +5 more
20104 citations
Semantic Scholar
ATRA Upregulates Cell Surface CD1D on Myeloma Cells and Sensitizes Them to iNKT Cell-Mediated Lysis
Xin Li, T. Garg, Sarah K. Johnson, S. Szmania +7 more
20143 citations
Semantic Scholar
Curing Multiple Myeloma (MM) with Total Therapy (TT)
B. Barlogie, A. Mitchell, F. van Rhee, J. Epstein +6 more
20143 citations
Semantic Scholar
Inducible Heme Oxygenase 1 (HMOX1) Promotes Osteoblastogenesis, and Inhibits Osteoclastogenesis and Myeloma-Induced Bone Disease
Xin Li, Sarah K. Johnson, W. Ling, Sharmin Khan +4 more
20113 citations
Semantic Scholar
Stearoyl CoA Desaturase 1 (SCD1) Is Upregulated in Rapidly Growing Myeloma Cells and Is Required for Cell Proliferation
S. U. Venkateshaiah, Sharmin Khan, W. Ling, L. John +3 more
20113 citations
Semantic Scholar
Analysis of the Metabolic State of Residual Multiple Myeloma Plasma Cells Reveals a Proliferative Subset with Glycolytic Gene Expression
Whitney Tevebaugh, James C. Douglas, B. Walker, C. Schinke +8 more
20172 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. van Rhee×32
Invite
F. van Rhee — researcher profile on SciRah
B. Barlogie×32
Invite
B. Barlogie — researcher profile on SciRah
J. Epstein×27
Invite
J. Epstein — researcher profile on SciRah
M. Zangari×23
Invite
M. Zangari — researcher profile on SciRah

×19

Invite

G. Morgan — researcher profile on SciRah

Invite

C. Schinke — researcher profile on SciRah

Invite

W. Ling — researcher profile on SciRah

S. Thanendrarajan×15

Invite

S. Thanendrarajan — researcher profile on SciRah

Invite

Xin Li — researcher profile on SciRah

Invite

F. Davies — researcher profile on SciRah

Sharmin Khan×13

Invite

Sharmin Khan — researcher profile on SciRah

Invite

A. Hoering — researcher profile on SciRah